Screening for prostate cancer with the prostate-specific antigen (PSA) test, once widely promoted for all men 50 years and older, has fallen out of favor as a population-based screening tool. But when it comes to PSA testing, the proverbial baby shouldn’t be thrown out with the bathwater, experts caution.
‘Screening Smarter’ for Prostate Cancer
source: Cancer Network